Evidence map›Paper›PMID 16579851›Full record

ArticleBMC bioinformatics2006

Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models.

Wen Liu, Xiangshan Meng, Qiqi Xu, Darren R Flower, Tongbin Li

Abstract read
In one paragraph

Article in BMC bioinformatics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Multi-epitope vaccines: a promising strategy against viral diseases in swine.Frontiers in cellular and infection microbiology · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Immunoinformatics: Predicting Peptide-MHC Binding.Annual review of biomedical data science · 2020
    Article
  14. Article
  15. Prediction of Anticancer Peptides Using a Low-Dimensional Feature Model.Frontiers in bioengineering and biotechnology · 2020
    Article
  16. Novel Strategies for Malaria Vaccine Design.Frontiers in immunology · 2018
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wen LiuDepartment of Neuroscience, University of Minnesota, Minneapolis, MN 55455, USA. liuwen@biocompute.umn.edu
Xiangshan Meng
Qiqi Xu
Darren R Flower
Tongbin Li

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe binding between peptide epitopes and major histocompatibility complex proteins (MHCs) is an important event in the cellular immune response. Accurate prediction of the binding between short peptides and the MHC molecules has long been a principal challenge for immunoinformatics. Recently, the modeling of MHC-peptide binding has come to emphasize quantitative predictions: instead of categorizing peptides as "binders" or "non-binders" or as "strong binders" and "weak binders", recent methods seek to make predictions about precise binding affinities.

resultsWe developed a quantitative support vector machine regression (SVR) approach, called SVRMHC, to model peptide-MHC binding affinities. As a non-linear method, SVRMHC was able to generate models that out-performed existing linear models, such as the "additive method". By adopting a new "11-factor encoding" scheme, SVRMHC takes into account similarities in the physicochemical properties of the amino acids constituting the input peptides. When applied to MHC-peptide binding data for three mouse class I MHC alleles, the SVRMHC models produced more accurate predictions than those produced previously. Furthermore, comparisons based on Receiver Operating Characteristic (ROC) analysis indicated that SVRMHC was able to out-perform several prominent methods in identifying strongly binding peptides.

conclusionAs a method with demonstrated performance in the quantitative modeling of MHC-peptide binding and in identifying strong binders, SVRMHC is a promising immunoinformatics tool with not inconsiderable future potential.

Indexed as

Quantitative Structure-Activity RelationshipAlgorithmsAmino Acid SequenceAnimalsArtificial IntelligenceBinding SitesComputer SimulationHistocompatibility Antigens Class IMiceModels, ChemicalModels, MolecularMolecular Sequence DataPattern Recognition, AutomatedPeptidesProtein BindingProtein Interaction MappingHistocompatibility Antigens Class IPeptides

Identifiers

PMID16579851
PMCPMC1513606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.